User profiles for Jonathan M Chemouny

Jonathan Chemouny

CHU de Rennes
Verified email at chu-rennes.fr
Cited by 1535

An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants

…, D Bertrand, C Colosio, L Couzi, JM Chemouny… - Kidney international, 2020 - Elsevier
Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

Is COVID‐19 infection more severe in kidney transplant recipients?

…, A Thierry, L Couzi, JM Chemouny… - American Journal of …, 2021 - Wiley Online Library
There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Occurrence of severe COVID-19 in vaccinated transplant patients

…, P Gatault, A Sicard, JM Chemouny… - Kidney …, 2021 - kidney-international.org
1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19
vaccine. N Engl J Med. 2020; 383: 2603-2615. 2. Baden LR, El Sahly HM, Essink B, et al. …

Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review

…, J Supervielle, JM Chemouny… - Clinical Kidney …, 2021 - academic.oup.com
Although pregnancy remains exceptional in women after heart, liver or lung transplant,
obstetricians and nephrologists are regularly confronted with pregnancy in renal transplant …

[HTML][HTML] Gluten exacerbates IgA nephropathy in humanized mice through gliadin–CD89 interaction

…, E Pillebout, JM Chemouny, M Jablonski, M Flamant… - Kidney international, 2015 - Elsevier
IgA1 complexes containing deglycosylated IgA1, IgG autoantibodies, and a soluble form of
the IgA receptor (sCD89), are hallmarks of IgA nephropathy (IgAN). Food antigens, notably …

Role of IgA receptors in the pathogenesis of IgA nephropathy

SM Lechner, C Papista, JM Chemouny, L Berthelot… - Journal of …, 2016 - Springer
Immunoglobulin A nephropathy (IgAN) or Berger’s disease is the most common form of
primary glomerulonephritis in the world and one of the first causes of end-stage renal failure. …

Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice

JM Chemouny, PJ Gleeson, L Abbad… - Nephrology Dialysis …, 2019 - academic.oup.com
Background Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide. IgA is mainly produced by the gut-associated lymphoid tissue (GALT). …

[HTML][HTML] The IgA1 immune complex–mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA …

…, JM Chemouny, LR Kafkova, L Berthelot, M Flamant… - Kidney international, 2012 - Elsevier
IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, has
significant morbidity and mortality as 20–40% of patients progress to end-stage renal disease …

[HTML][HTML] Fecal microbiota transplantation modulates renal phenotype in the humanized mouse model of IgA nephropathy

…, L Abbad, M Vacca, G Celano, JM Chemouny… - Frontiers in …, 2021 - frontiersin.org
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis.
Several observations suggest that gut microbiota could be implicated in IgAN pathophysiology. …

[HTML][HTML] Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs

…, F Marquet, M Jablonski, JM Chemouny… - Nature …, 2018 - nature.com
In systemic lupus erythematosus (SLE), autoantibody production can lead to kidney damage
and failure, known as lupus nephritis. Basophils amplify the synthesis of autoantibodies by …